Download our latest report "The Untapped Climate Opportunity in Alternative Proteins Read more x
Press releases

Blue Horizon announces Seed investment in Cultivated Biosciences 

Zurich, Switzerland, 6 September 2022 – Blue Horizon, a next generation impact investor accelerating the transition to a new Sustainable Food System, today announced a Seed investment in Cultivated Biosciences.

Blue Horizon today announced a Seed investment in Cultivated Biosciences, a company founded by the Swiss entrepreneurs Tomas Turner and Dimitri Zogg. The round was led by the Swiss investor Wingman Ventures alongside other leading foodtech VC investors such as Big Idea Ventures and Proveg International. In addition, a group of angel investors from the industry participated in the round; industry leaders such as the Founder & CEO of EVERY™ Arturo Elizondo, the Co-Founder of Planted™ Lukas Böni , and other angels within the FoodHack syndicate.

Cultivated Biosciences Founders

Cultivated Biosciences’ mission is to change the way the world thinks about alternative fats within the dairy category. From their labs in Zurich, they are developing a creamy ingredient from GMO-free yeast which offers the creaminess needed for plant-based dairy. This ingredient has a clean label and sustainable production process.

In 2023, Cultivated Biosciences will start testing its creamy ingredient with selected clients for high-value savory applications and are open to interested partners.

Tomas Turner, Co-Founder and CEO of Cultivated Biosciences, said: “We are beyond excited to build a solution that will elevate the mouthfeel of the plant-based dairy category and ensure that it’s simply better and cheaper than its factory-farmed equivalent.”

Robert Boer, Director at Blue Horizon, said: “Cultivated Biosciences is tackling a very important bottleneck in the adoption of plant-based dairy. We want our yoghurts, ice creams and spreads really creamy without compromising taste and mouthfeel. Combining scalable and cost-effective fermentation technology with mission-driven founders makes us very excited to support this Swiss company located in our HQ’s backyard.”

To date, Blue Horizon has raised funds of over $850 million and invested in 75+ companies with a focus on protein alternatives and food tech. Some of the firm’s investments include Tropic Biosciences, a pioneering agricultural biotechnology company focused on a crop portfolio of bananas, coffee and rice, Planted, one of the emerging leaders of plant-based meat alternatives and Mosa Meat, which is developing tissue engineering technologies to mass produce affordable, cultured meat and dairy formulation.

Blue Horizon announces Seed investment in Cultivated Biosciences